Williams Dantaya M 4

4 · RTX Corp · Filed Feb 6, 2025

Form 4

Period: 2025-02-05

EVP & Chief HR Officer

Transactions

Exercise/Conversion
Stock Appreciation Right
2025-02-05−10,118→ 0 total
Exercise: $90.73From: 2023-02-04Exp: 2030-02-03→ Common Stock (10,118 underlying)
Exercise/Conversion
Common Stock
2025-02-05$72.49/sh+25,100$1,819,499→ 48,327.616 total
Exercise/Conversion
Common Stock
2025-02-05$90.73/sh+10,118$918,006→ 58,445.616 total
Disposition to Issuer
Common Stock
2025-02-05$129.20/sh−21,187$2,737,360→ 23,227.616 total
Sale
Common Stock
2025-02-05$129.23/sh−14,031$1,813,291→ 44,414.616 total
Exercise/Conversion
Stock Appreciation Right
2025-02-05−25,100→ 0 total
Exercise: $72.49From: 2024-02-08Exp: 2031-02-07→ Common Stock (25,100 underlying)

Holdings

Footnotes (2)

[F1]The Stock Appreciation Rights (SARs) were settled in shares in accordance with the terms of the award. For Section 16 reporting purposes, the exercise of SARs for stock is treated as an exempt acquisition of the shares underlying the SARs at the exercise price per share specified in the award of SARs and a simultaneous sale back to the issuer of a number of the underlying shares having a value, based on the market price of the issuer's stock on the date of the exercise, equal to the product of the number of underlying SARs times the exercise price per share.
[F2]The reported price is based on a weighted average of multiple same-day transactions with prices ranging from $129.20 to $129.285 per share. Full information regarding the number of shares sold at each separate price is available to the Securities and Exchange Commission, the Issuer or any security holder of the Issuer upon request.

Documents

1 file